Clinical trials: Positive E Coli Infections

Malaria

Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults

• Completed
• Age: 18 to 50 years
• Phase 1
• Vaccines
• Results posted

Malaria has remained a major concern for the US military. During World War II, malaria was the leading cause of disease and non-battle injury with 500-700 men infected per day, resulting in 24,000 malaria-related casualties.(10)…

Trial name

NCT01540474

Testing

Group 1: 10 ug FMP012 with 2 ug GLA-SE, Group 2: 10 ug FMP012 with 5 ug GLA-SE, 50 ug FMP012 with 5 ug GLA-SE or 2 ug GLA-SE

Where

United States

Volunteers

36 people, healthy volunteers welcome

Sponsor

U.S. Army Medical Research and Development Command